Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
2
×
boston blog main
boston top stories
2
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
activism
acute hepatic porphyria
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
bernie sanders
biomarin pharmaceutical
biotech
bluebird bio
bristol-myers squibb
What
bio
2
×
drug
gene
2
×
roundup
therapy
advanced
alnylam’s
approval
aren’t
bff
conference
deals
developers
devoted
disease
drugs
easl
fda
form
help
imminent
kicked
liver
long
major
medicare
moves
news
noteworthy
patients
prices
race
road
rulings
separate
they’ll
treat
updates
winding
world's
Language
Current search:
gene
×
" boston top stories "
×
bio
×
" alnylam pharmaceuticals "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
6 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More